Goldman Sachs Group Inc Akouos, Inc. Transaction History

Goldman Sachs Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 May 14, 2024	BUY	$2.6 - $5.16 $9,924 - $19,695	3,817 Added 15.33%	28,722 $194,000
Q3 2022 Nov 10, 2022	BUY	$2.6 - $5.16 $9,924 - $19,695	3,817 Added 15.33%	28,722 $0
Q2 2022 May 14, 2024	BUY	$2.46 - $5.2 $61,266 - $129,506	24,905 New	24,905 $0
Q2 2022 Aug 15, 2022	SELL	$2.46 - $5.2 $50,570 - $106,896	-20,557 Reduced 45.22%	24,905 $116,000
Q1 2022 May 16, 2022	BUY	$4.16 - $9.08 $33,762 - $73,693	8,116 Added 21.73%	45,462 $216,000
Q4 2021 Feb 14, 2022	SELL	$7.65 - $11.38 $389,048 - $578,741	-50,856 Reduced 57.66%	37,346 $317,000
Q3 2021 Nov 10, 2021	BUY	$9.93 - $13.59 $875,845 - $1.2 Million	88,202 New	88,202 $1.02 Million

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.